Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
€ 121,00 0.00 (0.00%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionFca Corp /tx
Latest Disclosed Ownership22,851 shares
Latest Disclosed Value $ 3,490,490
Fca Corp /tx reports 1.06% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 14, 2026 - Fca Corp /tx filed a 13F-HR form disclosing ownership of 22,851 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $2,936,354 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 22,612 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 1.06% during the quarter. The current value of the position is $2,764,971 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 22,851 239 1.06 3,490 11.97 0.9538
2026-02-11 2025-12-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 22,612 -1,820 -7.45 3,118 -0.51 0.8801
2025-11-14 2025-09-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 24,432 363 1.51 3,133 7.59 0.8701
2025-08-12 2025-06-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 24,069 519 2.20 2,913 10.93 0.8720
2025-05-13 2025-03-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 23,550 -664 -2.74 2,625 11.42 0.8371
2025-02-11 2024-12-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 24,214 398 1.67 2,356 -13.98 0.7358
2024-11-13 2024-09-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 23,816 148 0.63 2,739 8.73 0.8401
2024-08-13 2024-06-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 23,668 419 1.80 2,520 12.06 0.8063
2024-05-08 2024-03-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 23,249 -55 -0.24 2,249 -4.46 0.7275
2024-02-08 2023-12-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 23,304 28 0.12 2,353 -0.72 0.8089
2023-11-13 2023-09-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 23,276 750 3.33 2,371 4.27 0.8840
2023-08-14 2023-06-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 22,526 -173 -0.76 2,273 8.86 0.8431
2023-05-12 2023-03-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 22,699 568 2.57 2,088 4.04 0.7835
2023-02-14 2022-12-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 22,131 75 0.34 2,008 19.75 0.8073
2022-11-14 2022-09-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 22,056 555 2.58 1,676 -7.76 0.7117
2022-08-12 2022-06-30 13F NOVARTIS ADR 66987V109 21,501 310 1.46 1,817 -2.31 0.7159
2022-05-13 2022-03-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 21,191 830 4.08 1,860 4.44 0.6492
2022-02-14 2021-12-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 20,361 -3,151 -13.40 1,781 -7.38 0.6063
2021-11-12 2021-09-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 23,512 241 1.04 1,923 -9.42 0.5788
2021-08-13 2021-06-30 13F Novartis Ag-Sponsored Adr ADR 66987V109 23,271 -111 -0.47 2,123 6.20 0.6012
2021-05-12 2021-03-31 13F Novartis COM 66987V109 23,382 -59 -0.25 1,999 -9.71 0.5844
2021-03-04 2020-12-31 13F/A-1 Novartis ADR 66987V109 23,441 444 1.93 2,214 10.70 0.7098
2021-02-12 2020-12-31 13F Novartis ADR 66987V109 23,441 444 2,214 685,427.6957
2020-11-12 2020-09-30 13F Novartis Ag-Sponsored Adr ADR 66987V109 22,997 -442 -1.89 2,000 -2.30 0.6866
2020-08-13 2020-06-30 13F Novartis COM 66987V109 23,439 -39 -0.17 2,047 5.73 0.7802
2020-05-20 2020-03-31 13F/A-1 Novartis COM 66987V109 23,478 544 2.37 1,936 -10.87 0.8474
2020-05-19 2020-03-31 13F Novartis COM 66987V109 22,934 0 2,172 743,288.3322
2020-02-11 2019-12-31 13F Novartis COM 66987V109 22,934 -44 -0.19 2,172 8.76 0.7536
2019-11-06 2019-09-30 13F Novartis COM 66987V109 22,978 -450 -1.92 1,997 -6.64 0.7442
2019-08-13 2019-06-30 13F Novartis COM 66987V109 23,428 350 1.52 2,139 -3.61 0.7829
2019-05-14 2019-03-31 13F Novartis COM 66987V109 23,078 -339 -1.45 2,219 10.45 0.8633
2019-03-29 2018-12-31 13F/A-1 Novartis COM 66987V109 23,417 -178 -0.75 2,009 -1.18 0.9034
2019-02-14 2018-12-31 13F Novartis COM 66987V109 23,417 -178 2,009
2018-10-22 2018-09-30 13F Novartis COM 66987V109 23,595 -289 -1.21 2,033 12.69 0.7764
2018-08-10 2018-06-30 13F Novartis COM 66987V109 23,884 -553 -2.26 1,804 -12.09 0.7195
2018-02-13 2017-12-31 13F Novartis COM 66987V109 24,437 -110 -0.45 2,052 -2.61 0.8175
2017-11-09 2017-09-30 13F Novartis COM 66987V109 24,547 -96 -0.39 2,107 2.43 0.8706
2017-08-04 2017-06-30 13F Novartis ADR 66987V109 24,643 120 0.49 2,057 12.96 0.8999
2017-05-08 2017-03-31 13F Novartis ADR 66987V109 24,523 760 3.20 1,821 5.20 0.8583
2017-02-09 2016-12-31 13F Novartis ADR 66987V109 23,763 85 0.36 1,731 -7.43 0.8613
2016-11-09 2016-09-30 13F Novartis ADR 66987V109 23,678 -730 -2.99 1,870 -7.15 0.9676
2016-08-04 2016-06-30 13F Novartis ADR 66987V109 24,408 -3,394 -12.21 2,014 0.00 1.0283
2016-05-13 2016-03-31 13F Novartis ADR 66987V109 27,802 -777 -2.72 2,014 -18.10 1.0696
2016-02-05 2015-12-31 13F Novartis ADR 66987V109 28,579 3,320 13.14 2,459 5.90 1.4275
2015-11-09 2015-09-30 13F Novartis Ag-Sponsored Adr ADR 66987V109 25,259 610 2.47 2,322 -4.21 1.3487
2015-08-11 2015-06-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 24,649 -170 -0.68 2,424 -0.94 1.3384
2015-05-12 2015-03-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 24,819 229 0.93 2,447 7.37 1.3234
2015-02-13 2014-12-31 13F NOVARTIS AG-ADR ADR 66987V109 24,590 -288 -1.16 2,279 -2.69 1.3043
2014-11-17 2014-09-30 13F NOVARTIS AG-ADR ADR 66987V109 24,878 0 0.00 2,342 4.00 1.3078
2014-08-14 2014-06-30 13F/A-1 NOVARTIS AG-ADR ADR 66987V109 24,878 -470 2,252 1.2366
2014-09-08 2014-06-30 13F/A-2 NOVARTIS AG-ADR ADR 66987V109 24,878 -470 -1.85 2,252 1.44 1.2367
2014-08-12 2014-06-30 13F NOVARTIS AG-ADR COM 66987V109 24,878 1,816
2014-09-08 2014-03-31 13F/A-1 NOVARTIS AG-ADR ADR 66987V109 25,348 -1,075 -4.07 2,220 4.52 1.3552
2014-05-14 2014-03-31 13F NOVARTIS AG-ADR ADR 66987V109 25,348 2,220
2014-02-12 2013-12-31 13F NOVARTIS AG-ADR ADR 66987V109 26,423 -400 -1.49 2,124 3.16 1.2287
2014-09-08 2013-09-30 13F/A-1 NOVARTIS AG-ADR ADR 66987V109 26,823 -155 -0.57 2,059 7.91 1.2238
2013-11-06 2013-09-30 13F NOVARTIS AG-ADR ADR 66987V109 26,823 2,059
2013-08-09 2013-06-30 13F NOVARTIS AG-ADR ADR 66987V109 26,978 26,978 1,908 1.1930
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.